Patent: 10,555,993
✉ Email this page to a colleague
Summary for Patent: 10,555,993
| Title: | Dimethyl fumarate and vaccination regimens |
| Abstract: | Provided herein is a method of treating or preventing a disease or disorder (e.g., MS) in a subject in need thereof, comprising (a) administering to the subject a first dose of a pharmaceutical composition comprising a fumarate agent (e.g., DMF) for a first dosing period; (b) administering a vaccine; and (c) administering to the subject a second dose of the pharmaceutical composition for a second dosing period. |
| Inventor(s): | Viglietta; Vissia (Boston, MA) |
| Assignee: | Biogen MA Inc. (Cambridge, MA) |
| Application Number: | 16/391,583 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 10,555,993 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,555,993
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Merck Sharp & Dohme Llc | PNEUMOVAX 23 | pneumococcal vaccine, polyvalent | Injection | 101094 | 21-Nov-77 | ⤷ Start Trial | 2039-04-23 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
